Skip to Main Content

Author Details

Arik A Zur
Schools of Pharmacy and Medicine, University of California san francisco
2009
16
12
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
32910949Drug Metabolites Potently Inhibit Renal Organic Anion Transporters, OAT1 and OAT3.J Pharm Sci2021
32237115The Effect of CYP3A Induction and Inhibition on the Pharmacokinetics of Laquinimod, a Novel Neuroimmunomodulator.Clin Pharmacol Drug Dev2020
30191262The effect of laquinimod, a novel immuno-modulator in development to treat Huntington disease, on the pharmacokinetics of ethinylestradiol and levonorgestrel in healthy young women.Eur J Clin Pharmacol2019
31889898AGI-134: a fully synthetic α-Gal glycolipid that converts tumors into in situ autologous vaccines, induces anti-tumor immunity and is synergistic with an anti-PD-1 antibody in mouse melanoma models.Cancer Cell Int2019
30347454Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug-Drug Interaction Evaluation: Perspectives From the International Transporter Consortium.Clin Pharmacol Ther2018
30048132Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).J Med Chem2018
28562037Computational Discovery and Experimental Validation of Inhibitors of the Human Intestinal Transporter OATP2B1.J Chem Inf Model2017
26700958Rapid Method To Determine Intracellular Drug Concentrations in Cellular Uptake Assays: Application to Metformin in Organic Cation Transporter 1-Transfected Human Embryonic Kidney 293 Cells.Drug Metab Dispos2016
26597253The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of Metformin.Clin Pharmacokinet2016
27624080LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.Bioorg Med Chem Lett2016
27447836Metabolomic and Genome-wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1.Clin Pharmacol Ther2016
27106710LAT-1 activity of meta-substituted phenylalanine and tyrosine analogs.Bioorg Med Chem Lett2016
24961373OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin.Proc Natl Acad Sci U S A2014
23241029Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.J Med Chem2013
23588305Emerging transporters of clinical importance: an update from the International Transporter Consortium.Clin Pharmacol Ther2013
19670021The challenge of pain management in patients with myasthenia gravis.J Pain Palliat Care Pharmacother2009
  • 1 - 16 of 16

Recommended Authors

Giovanni Bocci
The University of New Mexico School of Medicine
Career Start Year 2016
Number of shared co-authors 0
Pajaree Chariyavilaskul
Chulalongkorn University
Career Start Year 2013
Number of shared co-authors 0
Kunal S Taskar
Drug Metabolism and Pharmacokinetics
Career Start Year 2009
Number of shared co-authors 2
Jason A Sprowl
School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Career Start Year 2007
Number of shared co-authors 3
Rasmus Jansson-L??fmark
Unit for Pharmacokinetics and Drug Metabolism, University of Gothenburg
Career Start Year 2005
Number of shared co-authors 0
Shuiying Hu
The Ohio State University
Career Start Year 2005
Number of shared co-authors 4
Li Gong
Stanford University
Career Start Year 2004
Number of shared co-authors 2
Bradley L Urquhart
Schulich School of Medicine and Dentistry, Western University
Career Start Year 2003
Number of shared co-authors 0
Leslie W Chinn
Genentech Inc.
Career Start Year 2003
Number of shared co-authors 3
Noel Southall
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 2002
Number of shared co-authors 0
Craig J Thomas
Center for Cancer Research, National Cancer Institute
Career Start Year 2001
Number of shared co-authors 0
Eric Gangl
Oncology R&D
Career Start Year 1998
Number of shared co-authors 0
Salvador Fudio
Clinical Development
Career Start Year 1998
Number of shared co-authors 0
Alice A Gibson
The Ohio State University
Career Start Year 1997
Number of shared co-authors 2
Mary F Paine
Washington State University
Career Start Year 1996
Number of shared co-authors 2
Matthias Schwab
and of Biochemistry and Pharmacy, University of Tuebingen
Career Start Year 1996
Number of shared co-authors 4
Anne T Nies
and University of Tuebingen, University of Tuebingen
Career Start Year 1995
Number of shared co-authors 3
Alex Sparreboom
Ohio State University
Career Start Year 1994
Number of shared co-authors 5
Zhuyin Li
National Center for Advancing Translational Sciences, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 0
Sharyn D Baker
Ohio State University
Career Start Year 1994
Number of shared co-authors 2
Tudor I Oprea
Expert Systems Inc.
Career Start Year 1993
Number of shared co-authors 1
Xi-Ping Huang
University of North Carolina School of Medicine
Career Start Year 1992
Number of shared co-authors 3
Mark Namchuk
Blavatnik Institute, Harvard Medical School
Career Start Year 1990
Number of shared co-authors 0
Giuliano Ciarimboli
University Hospital Munster
Career Start Year 1989
Number of shared co-authors 2
Francois Pognan
Novartis
Career Start Year 1988
Number of shared co-authors 1
Antonio Macchiarulo
Department of Pharmaceutical Sciences, University of Perugia
Career Start Year 1986
Number of shared co-authors 0
Scott J Weir
University of Kansas Medical Center
Career Start Year 1985
Number of shared co-authors 0
Per Artursson
Department of Pharmacy, Uppsala University
Career Start Year 1983
Number of shared co-authors 7
Lawrence J Lesko
Department of Pharmaceutics, University of Florida
Career Start Year 1979
Number of shared co-authors 0
Wolfgang Sad??e
College of Medicine, The Ohio State University
Career Start Year 1967
Number of shared co-authors 4

Collaborators

Kathleen M Giacomini
University of California San Francisco
Co-authored papers 12
Sook Wah Yee
University of California San Francisco
Co-authored papers 5
Huan-Chieh Chien
University of California San Francisco
Co-authored papers 5
Lawrence Lin
University of California San Francisco
Co-authored papers 3
Matthias Wittwer
F. Hoffmann-La Roche Ltd.
Co-authored papers 3
Avner Schlessinger
Department of Pharmacological Sciences, Icahn School of Medicine at Mount Sinai
Co-authored papers 3
Kari M Morrissey
Amunix Pharmaceuticals
Co-authored papers 2
Natalia Khuri
Stanford University
Co-authored papers 2
Xiaomin Liang
Gilead Sciences Inc.
Co-authored papers 2
Xuexiang Zhang
Baruch S. Blumberg Institute
Co-authored papers 2
Yong Huang
Collegeville
Co-authored papers 2
Andrej Sali (CM4AI)
University of California San Francisco
Co-authored papers 2
Alan Kosaka
Roche Palo Alto LLC
Co-authored papers 1
Ligong Chen
Tsinghua University
Co-authored papers 1
Kevan M Shokat
University of California San Francisco
Co-authored papers 1
Yasuto Kido
Shionogi & Co.
Co-authored papers 1
Eugene C Chen
Department of Drug Metabolism and Pharmacokinetics, Inc.
Co-authored papers 1
Deanna L Kroetz
University of California San Francisco
Co-authored papers 1
Richard A Castro
University of California san francisco
Co-authored papers 1
Adrian Stecula
Schools of Pharmacy and Medicine, University of California san francisco
Co-authored papers 1
P??r Matsson
University of Gothenburg
Co-authored papers 1
Release 1.2